Investor Relations

Corporate Profile

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. A vertically integrated, seed-to-sale enterprise, Emerald has combined core competencies from decades of experience in pharmaceutical innovation with large-scale agriculture expertise focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

 

 

Stock Information

Copyright West LLC. Minimum 15 minutes delayed.

Strategic Network

Pure SunFarms 

  • 50/50 joint venture with Village Farms, a converted 1.1M square foot greenhouse growing facility with cultivation and sales license

Agro-Biotech 

  • Wholly-owned subsidiary
  • 75,000 square foot indoor facility in Québec with a cultivation license

Hemp sourcing 

  • Secured a long-term supply contract for approximately 500 acres of hemp in 2018 and up to 1000 acres in 2019 to 2022 to provide low-cost cannabidiol (CBD) supply for extraction and product manufacturing

Northern Vine Labs

  • Wholly-owned subsidiary
  • Licensed Dealer and analytical testing of cannabis 
  • International government approvals to import and export cannabis oils for research & development

Emerald Health Naturals

  • 51/49 joint venture with Emerald Health Bioceuticals to sell non-cannabis natural health products for endocannabinoid system

Victoria 

  • Wholly-owned subsidiary 
  • Product development facility

Featured Reports

Dec 10, 2018
Dec 10, 2018